https://media.ideayabio.com/ https://media.ideayabio.com/2026-03-09-IDEAYA-Biosciences-Announces-First-Patient-In-for-Phase-1-Trial-of-IDE892,-a-Potential-Best-In-Class-PRMT5-Inhibitor-for-MTAP-Deleted-Solid-Tumors,-and-Provides-MTAP-and-CDKN2A-Pipeline-Update Mon, 09 Mar 2026 06:00:00 -0400 https://media.ideayabio.com/2026-03-09-IDEAYA-Biosciences-Announces-First-Patient-In-for-Phase-1-Trial-of-IDE892,-a-Potential-Best-In-Class-PRMT5-Inhibitor-for-MTAP-Deleted-Solid-Tumors,-and-Provides-MTAP-and-CDKN2A-Pipeline-Update https://media.ideayabio.com/2026-02-27-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 Fri, 27 Feb 2026 06:00:00 -0500 https://media.ideayabio.com/2026-02-27-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 https://media.ideayabio.com/2026-02-25-IDEAYA-Biosciences-Announces-First-Patient-In-for-Phase-1-Trial-of-IDE034,-a-Potential-First-In-Class-B7H3-PTK7-Bispecific-TOP1-ADC Wed, 25 Feb 2026 06:00:00 -0500 https://media.ideayabio.com/2026-02-25-IDEAYA-Biosciences-Announces-First-Patient-In-for-Phase-1-Trial-of-IDE034,-a-Potential-First-In-Class-B7H3-PTK7-Bispecific-TOP1-ADC https://media.ideayabio.com/2026-02-23-IDEAYA-Biosciences-Announces-Appointment-of-Dr-Theodora-Theo-Ross,-M-D-,-Ph-D-,-as-Chief-Development-Officer Mon, 23 Feb 2026 06:00:00 -0500 https://media.ideayabio.com/2026-02-23-IDEAYA-Biosciences-Announces-Appointment-of-Dr-Theodora-Theo-Ross,-M-D-,-Ph-D-,-as-Chief-Development-Officer https://media.ideayabio.com/2026-02-17-IDEAYA-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update Tue, 17 Feb 2026 06:00:00 -0500 https://media.ideayabio.com/2026-02-17-IDEAYA-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update